Company Profile

Focused on your needs

A simple, unified Teva offers adaptive and accessible solutions for patients

We at Teva are committed to putting people at the center of what we do. By building on our strong global presence and harnessing our size and scale, we are increasing access to quality health solutions with the potential to help millions of people around the world. We do this by striving to develop and produce affordable, high-quality generic drugs, innovative specialty pharmaceuticals, and active pharmaceutical ingredients.

It is our employees who are at the core of our success as a global pharmaceutical leader and the world’s largest generic medicines producer. We have colleagues in over 60 countries that develop, produce, and deliver the “world’s largest medicine cabinet” to 200 million people every day 01.

By simplifying and unifying our business, we are working to meet the needs of our stakeholders and keep our promise to build a sustainable business. Our goal is to meet the current needs of patients and caregivers by continually developing our diverse portfolio of products and solutions, and we strive to anticipate future patient needs by evolving through research and development through key therapeutic areas, business development, and innovation. 

We wake up with pride every morning knowing that we help improve people's lives, while ensuring the highest standards of compliance and business integrity in everything we do.

Meet Teva’s Corporate Officers

 

Many things in life can be counted. At Teva we focus on the things that count.

Teva Pharmaceuticals has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 different products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of biopharmaceutical products. Learn more at www.tevapharm.com


Footnotes

  1. Back to contents.

    Teva annual report filing 2018

Share this article: